Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corteva (CTVA) Accumulated Expenses (2018 - 2025)

Corteva has reported Accumulated Expenses over the past 8 years, most recently at $3.1 billion for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 47.36% year-over-year to $3.1 billion; the TTM value through Dec 2025 reached $3.1 billion, up 47.36%, while the annual FY2025 figure was $3.1 billion, 47.36% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $3.1 billion at Corteva, up from $2.7 billion in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $3.1 billion in Q4 2025 and troughed at $2.1 billion in Q4 2021.
  • A 5-year average of $2.4 billion and a median of $2.3 billion in 2022 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: dropped 13.59% in 2024 and later skyrocketed 47.36% in 2025.
  • Year by year, Accumulated Expenses stood at $2.1 billion in 2021, then grew by 8.99% to $2.3 billion in 2022, then grew by 4.3% to $2.4 billion in 2023, then dropped by 10.55% to $2.1 billion in 2024, then skyrocketed by 47.36% to $3.1 billion in 2025.
  • Business Quant data shows Accumulated Expenses for CTVA at $3.1 billion in Q4 2025, $2.7 billion in Q3 2025, and $2.9 billion in Q2 2025.